Clinical trial
Phase 2a Safety Study of a Vaginal Matrix Ring Containing Dapivirine in a Postmenopausal Female Population
NCT02010593 is registered in ClinicalTrials.gov with International Partnership for Microbicides, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2a Safety Study of a Vaginal Matrix Ring Containing Dapivirine in a Postmenopausal Female Population
- Lead sponsor
- International Partnership for Microbicides, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- April 30, 2015
- Enrollment
- 96 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus